Ronald C. Renaud, Jr.

Ronald C. Renaud, Jr.
Translate Bio

Angela Rasmussen, PhD

Angela Rasmussen, PhD
Associate Research Scientist
Columbia University

Julianna LeMieux

Julianna LeMieux, PhD
Senior Science Writer

Alex Philippidis

Alex Philippidis
Senior Business Writer

Broadcast Date: September 16, 2020
Time: 2:00 pm ET

The COVID-19 pandemic has now claimed more than 500,000 lives, including 180,000 in the United States. The biotech and pharma industries are working furiously to develop therapeutics and a vaccine. Several vaccine candidates are now in the clinic, with promising early-stage results reported by Pfizer, AstraZeneca, and others.

Join us for Episode 4 of GEN Live, in which we discuss the state of vaccine development for COVID-19. We evaluate the front-runners, explore the potential of RNA vaccines, ponder the challenges of manufacturing, and tackle questions about herd immunity.

• Julianna LeMieux – GEN Senior Science Writer
• Alex Philippidis – GEN Senior Business Writer

Special Guests:
Ronald Renaud (CEO Translate Bio)
Angela Rasmussen, PhD (Center for Infection and Immunity, Columbia University Mailman School of Public Health)

Moderated by: Kevin Davies (GEN/The CRISPR Journal)


Produced with support from:

Tecan logo